About UMHAT "Sv. Ivan Rilski", EAD
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at UMHAT "Sv. Ivan Rilski", EAD
During the past decade, UMHAT "Sv. Ivan Rilski", EAD conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 36 clinical trials were completed, i.e. on
average, 58.1% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 26 clinical trials were completed. i.e. 113%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "UMHAT "Sv. Ivan Rilski", EAD" #1 sponsor was "Pfizer" with 11 trials, followed by "Hoffmann-La Roche" with 8 trials
sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Galapagos NV" with 5 trials sponsored and "Takeda"
with 5 trials sponsored. Other sponsors include 39 different institutions and
companies that sponsored additional 35 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UMHAT "Sv. Ivan Rilski", EAD"
#1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at UMHAT "Sv. Ivan Rilski", EAD
According to Clinical.Site data, the most researched conditions in "UMHAT "Sv. Ivan Rilski", EAD" are
"Rheumatoid Arthritis" (10 trials), "Systemic Lupus Erythematosus" (7 trials), "Arthritis, Rheumatoid" (6 trials), "Crohn's Disease" (5 trials) and "Lupus Erythematosus, Systemic" (4 trials). Many other conditions were trialed in "UMHAT "Sv. Ivan Rilski", EAD" in a lesser frequency.
Clinical Trials Intervention Types at UMHAT "Sv. Ivan Rilski", EAD
Most popular intervention types in "UMHAT "Sv. Ivan Rilski", EAD" are "Drug" (73 trials), "Biological" (6 trials) and "Other" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (29 trials), "Adalimumab" (4 trials), "Etrolizumab" (4 trials), "Guselkumab" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at UMHAT "Sv. Ivan Rilski", EAD
The vast majority of trials in "UMHAT "Sv. Ivan Rilski", EAD" are
77 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at UMHAT "Sv. Ivan Rilski", EAD
Currently, there are NaN active trials in "UMHAT "Sv. Ivan Rilski", EAD".
undefined are not yet recruiting,
14 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 40 completed trials in UMHAT "Sv. Ivan Rilski", EAD,
undefined suspended trials,
and 12 terminated clinical trials to date.
Out of the total trials that were conducted in UMHAT "Sv. Ivan Rilski", EAD, 6 "Phase 1"
clinical trials were conducted, 32 "Phase 2" clinical
trials and 39 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of UMHAT "Sv. Ivan Rilski", EAD
UMHAT "Sv. Ivan Rilski", EAD has several departments that took part in Clinical trials: "MBAL Sveti Ivan Rilski, Klinika po Gastroenterologia" - 3 trials